Literature DB >> 32610575

Erratum: Castellví, M. et al. Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy. Cancers 2020, 12, 713.

Marc Castellví1,2, Eudald Felip2,3, Ifeanyi Jude Ezeonwumelu1,2, Roger Badia1,2, Edurne Garcia-Vidal1,2, Maria Pujantell1,2, Lucía Gutiérrez-Chamorro1,2, Iris Teruel2,3, Anna Martínez-Cardús2,3, Bonaventura Clotet1,2, Eva Riveira-Muñoz1,2, Mireia Margelí2,3, José A Esté1,4, Ester Ballana1,2.   

Abstract

The authors wish you make the following corrections to this paper[...].

Entities:  

Year:  2020        PMID: 32610575      PMCID: PMC7407514          DOI: 10.3390/cancers12071728

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


The authors wish you make the following corrections to this paper [1]. One contributor’s name was missing in the original version of the authorship. The original version of the authorship is: Marc Castellví and should be replaced with: Marc Castellví The updated “Author Contributions” should be
  1 in total

1.  Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy.

Authors:  Marc Castellví; Eudald Felip; Ifeanyi Jude Ezeonwumelu; Roger Badia; Edurne Garcia-Vidal; Maria Pujantell; Lucía Gutiérrez-Chamorro; Iris Teruel; Anna Martínez-Cardús; Bonaventura Clotet; Eva Riveira-Muñoz; Mireia Margelí; Ester Ballana
Journal:  Cancers (Basel)       Date:  2020-03-18       Impact factor: 6.639

  1 in total
  1 in total

1.  Modulation of DNA Damage Response by SAM and HD Domain Containing Deoxynucleoside Triphosphate Triphosphohydrolase (SAMHD1) Determines Prognosis and Treatment Efficacy in Different Solid Tumor Types.

Authors:  Eudald Felip; Lucía Gutiérrez-Chamorro; Maica Gómez; Edurne Garcia-Vidal; Margarita Romeo; Teresa Morán; Laura Layos; Laia Pérez-Roca; Eva Riveira-Muñoz; Bonaventura Clotet; Pedro Luis Fernandez; Ricard Mesía; Anna Martínez-Cardús; Ester Ballana; Mireia Margelí
Journal:  Cancers (Basel)       Date:  2022-01-27       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.